MFS
OREX

MSI Financial Services’s Orexigen Therapeutics, Inc. OREX Stock Holding History

MSI Financial Services’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$0 Hold
47
– – ﹤0.01% 4249
2016
Q3 		$0 Sell
47
-1
-2% -$4 ﹤0.01% 4282
2016
Q2 		$0 Sell
48
-39
-45% -$176 ﹤0.01% 4329
2016
Q1 		$0 Hold
87
– – ﹤0.01% 4326
2015
Q4 		$1K Sell
87
-10
-10% -$238 ﹤0.01% 3819
2015
Q3 		$2K Hold
97
– – ﹤0.01% 2886
2015
Q2 		$5K Sell
97
-5
-5% -$299 ﹤0.01% 2499
2015
Q1 		$8K Buy
102
+92
+920% +$5.71K ﹤0.01% 2277
2014
Q4 		$1K Hold
10
– – ﹤0.01% 2618
2014
Q3 		$0 Sell
10
-100
-91% -$5.37K ﹤0.01% 2882
2014
Q2 		$7K Buy
110
+100
+1,000% +$5.82K ﹤0.01% 1980
2014
Q1 		$1K Hold
10
– – ﹤0.01% 2484
2013
Q4 		$1K Hold
10
– – ﹤0.01% 2463
2013
Q3 		$1K Hold
10
– – ﹤0.01% 2120
2013
Q2 		$1K Buy
+10
New +$615 ﹤0.01% 2358

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FCMI
Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $923M AUM 112.31% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

MSI Financial Services's OREX Position: Q4 2016 in Review

MSI Financial Services held its Orexigen Therapeutics, Inc. (OREX) position steady in Q4 2016 at 47 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4249.

MSI Financial Services first reported a position in OREX in Q2 2013 and has held it in 15 quarters since. The position peaked at $8K in Q1 2015. 53 funds tracked by Wall St. Rank hold OREX as of Q4 2016.

  • MSI Financial Services held 47 shares of Orexigen Therapeutics, Inc. worth $0 as of Q4 2016.
  • MSI Financial Services left its Orexigen Therapeutics, Inc. share count unchanged in Q4 2016.
  • Orexigen Therapeutics, Inc. made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #4249 holding.
  • MSI Financial Services first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and has held it in 15 quarters since.
  • MSI Financial Services's Orexigen Therapeutics, Inc. position peaked at $8K in Q1 2015.
  • 53 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.